MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Schuheدهانات المدينة مصراتةAntwortenAntworten: دهانات المدينة مصراتة <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:18 Uhr</div>[url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url]: Researcher in Oncology Biology [url=https://www.instagram.com/hibou_sova/ ]Zoya Demidenko[/url] is a notable scholar connected with the Division of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she worked at the NIH and New York Medical College, building a solid background in life science investigation. Demidenko's academic work spans multiple critical areas, including the PI3K/AKT/mTOR signaling pathway, cell cycle control, cellular aging, and cancer science. To date, she has authored more than 46 peer-reviewed publications, which have received upwards of 4,100 citations — a testament to the significance of her research. One of her most notable contributions lies in explaining the processes of cell aging. Her research revealed that when the cellular division cycle is blocked while cellular growth proceeds, the cells experience senescence. Crucially, [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey= ]Zoya Demidenko[/url] established that this process can be controlled with drugs using substances such as mTOR inhibitors. [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/ ]Zoya Demidenko[/url] has additionally contributed considerably to tumor management investigation, especially in the domain of cyclotherapy — a approach intended to safeguarding normal tissue from anticancer drugs whilst leaving malignant cells susceptible. This approach carries major hope for reducing the adverse effects of cancer treatment. Across her professional journey, Demidenko has collaborated with leading scientists internationally, including Dr. Mikhail Blagosklonny. Her research can be found in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ ]Zoya Demidenko[/url] ranks as a highly impactful voice in current biomedical science, whose results keep to shape our understanding of how biological cells grow old, interact with treatment, and the ways in which cancer might be better treated. https://moodylab.smhs.gwu.edu/lab-members </blockquote><br> Abbrechen
